Pancreatic magnetic resonance imaging after manganese injection distinguishes type 2 diabetic and normoglycemic patients

Islets

Volumn 4, Issue 3, 2012, Pages 243-248

  Botsikas, Diomidis ^a   Terraz, Sylvain ^a   Vinet, Laurent ^b   Lamprianou, Smaragda ^b   Becker, Christoph D ^a   Bosco, Domenico ^a   Meda, Paolo ^b   Montet, Xavier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Diabetes; Imaging; Manganese; MEMRI; MRI

Indexed keywords

GADOLINIUM PENTETATE; GLUCOSE; INSULIN; MANGAFODIPIR;

AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET; SIGNAL NOISE RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EDETIC ACID; FEMALE; HUMANS; IMAGE ENHANCEMENT; INSULIN-SECRETING CELLS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PYRIDOXAL PHOSPHATE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84864396501     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.20857     Document Type: Article

References (30)

1. Leibiger IB, Caicedo A, Berggren PO. Non-invasive in vivo imaging of pancreatic beta-cell function and survival-a perspective. Acta Physiol (Oxf) 2011; PMID:21477063.
2. Gillespie KM. Type 1 diabetes: pathogenesis and prevention. CMAJ 2006; 175:165-70; PMID:16847277; http://dx.doi.org/10.1503/cmaj.060244.
3. Cernea S, Herold KC. Drug insight: New immunomodulatory therapies in type 1 diabetes. Nat Clin Pract Endocrinol Metab 2006; 2:89-98; PMID:16932263; http://dx.doi.org/10.1038/ncpendmet0082.
4. Yamaoka T. Regeneration therapy of pancreatic beta cells: towards a cure for diabetes? Biochem Biophys Res Commun 2002; 296:1039-43; PMID:12207876; http://dx.doi.org/10.1016/S0006-291X(02)02000-4.
5. Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation. Nat Med 2006; 12:144-8; PMID:16380717; http://dx.doi.org/10.1038/nm1316.
6. Ris F, Lepetit-Coiffe M, Meda P, Crowe LA, Toso C, Armanet M, et al. Assessment of human islet labeling with clinical grade iron nanoparticles prior to transplantation for graft monitoring by MRI. Cell Transplant 2010; 19:1573-85; PMID:20719068; http://dx.doi.org/10.3727/096368910X515863.
7. Lu Y, Dang H, Middleton B, Zhang Z, Washburn L, Stout DB, et al. Noninvasive imaging of islet grafts using positron-emission tomography. Proc Natl Acad Sci USA 2006; 103:11294-9; PMID:16868090; http://dx.doi.org/10.1073/ pnas.0603909103.
8. Souza F, Simpson N, Raffo A, Saxena C, Maffei A, Hardy M, et al. Longitudinal noninvasive PETbased beta cell mass estimates in a spontaneous diabetes rat model. J Clin Invest 2006; 116:1506-13; PMID:16710474; http://dx.doi.org/10.1172/JCI27645.
9. Pattou F, Kerr-Conte J, Wild D. GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle. N Engl J Med 2010; 363:1289-90; PMID:20860517; http://dx.doi.org/10.1056/NEJMc1004547.
10. Andralojc K, Srinivas M, Brom M, Joosten L, de Vries IJ, Eizirik DL, et al. Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis. Diabetologia 2012; 55:1247-57; PMID:22358499; http://dx.doi.org/10.1007/s00125- 012-2491-7.
11. Antkowiak PF, Tersey SA, Carter JD, Vandsburger MH, Nadler JL, Epstein FH, et al. Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging. Am J Physiol Endocrinol Metab 2009; 296:573-8; PMID:19116376; http://dx.doi.org/10.1152/ajpendo.90336.2008.
12. Gimi B, Leoni L, Oberholzer J, Braun M, Avila J, Wang Y, et al. Functional MR microimaging of pancreatic beta-cell activation. Cell Transplant 2006; 15:195-203; PMID:16719054; http://dx.doi.org/10.3727/000000006783982151.
13. Lamprianou S, Immonen R, Nabuurs C, Gjinovci A, Vinet L, Montet XC, et al. High-resolution magnetic resonance imaging quantitatively detects individual pancreatic islets. Diabetes 2011; 60:2853-60; PMID:21926272; http://dx.doi.org/10.2337/db11-0726.
14. Braun M. The αβδ of ion channels in human islet cells. Islets 2009; 1:160-2; PMID:21099266; http://dx.doi.org/10.4161/isl.1.2.9405.
15. Leoni L, Dhyani A, La Riviere P, Vogt S, Lai B, Roman BB. β-Cell subcellular localization of glucose-stimulated Mn uptake by X-ray fluorescence microscopy: implications for pancreatic MRI. Contrast Media Mol Imaging 2011; 6:474-81; PMID:22144025; http://dx.doi.org/10.1002/cmmi.447.
16. Mikulis DJ, Roberts TP. Neuro MR: protocols. J Magn Reson Imaging 2007; 26:838-47; PMID:17896388; http://dx.doi.org/10.1002/jmri.21041.
17. Meda P. Symposium on Beta-Cell Imaging at the 2011 EANM meeting. Imaging Med 2012; 4:17-23.
18. Vinet L, Lamprianou S, Goulley J, Nabuurs C, Immonen R, Babic A, et al. Towards an In Vivo portrait of pancreatic beta-cells: The bare essentials. Treatment Strategies Diabetes 2011; 3:43-7.
19. Brom M, Andrałoj K, Oyen WJ, Boerman OC, Gotthardt M. Development of radiotracers for the determination of the beta-cell mass in vivo. Curr Pharm Des 2010; 16:1561-7; PMID:20146667; http://dx.doi.org/10.2174/ 138161210791164126.
20. Medarova Z, Moore A. Non-invasive detection of transplanted pancreatic islets. Diabetes Obes Metab 2008; 10:88-97; PMID:18834436; http://dx.doi.org/10. 1111/j.1463-326.2008.00942.x.
21. Dryselius S, Grapengiesser E, Hellman B, Gylfe E. Voltage-dependent entry and generation of slow Ca2+ oscillations in glucose-stimulated pancreatic beta-cells. Am J Physiol 1999; 276:512-8; PMID:10070018.
22. Toft KG, Hustvedt SO, Grant D, Martinsen I, Gordon PB, Friisk GA, et al. Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol 1997; 38:677-89; PMID:9245963.
23. Wang C, Gordon PB, Hustvedt SO, Grant D, Sterud AT, Martinsen I, et al. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol 1997; 38:665-76; PMID:9245962.
24. Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R. Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci USA 2004; 101:12634-9; PMID:15304647; http://dx.doi.org/10.1073/pnas.0404307101.
25. Gaglia JL, Guimaraes AR, Harisinghani M, Turvey SE, Jackson R, Benoist C, et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest 2011; 121:442-5; PMID:21123946; http://dx.doi.org/10. 1172/JCI44339.
26. Sweet IR, Cook DL, Lernmark A, Greenbaum CJ, Wallen AR, Marcum ES, et al. Systematic screening of potential beta-cell imaging agents. Biochem Biophys Res Commun 2004; 314:976-83; PMID:14751228; http://dx.doi.org/10.1016/j.bbrc.2003. 12.182.
27. Mihic M, Modi P. Metabolic syndrome-risk factors for atherosclerosis and diabetes. Curr Diabetes Rev 2008; 4:122-8; PMID:18473759; http://dx.doi.org/10. 2174/157339908784220750.
28. Marchetti P, Bugliani M, Boggi U, Masini M, Marselli L. The pancreatic beta cells in human type 2 diabetes. Austin, TX: Landes Bioscence.
29. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008; 10:32-42; PMID:18834431; http://dx.doi.org/10.1111/j.1463-326.2008.00969. x.
30. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355:1318-30; PMID:17005949; http://dx.doi.org/10.1056/NEJMoa061267.